Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 09:54 am Purchase | 2025-12-31 | 13G | MONOPAR THERAPEUTICS INC MNPR | ASTRAZENECA PLC AZN | 522,667 7.800% | 135,338 (+34.94%) | Filing History |
| 2026-02-06 09:48 am Purchase | 2025-12-22 | 13D | INNATE PHARMA S A SPONSORED AD IPHA | ASTRAZENECA PLC AZN | 7,825,501 8.300% | 340,001 (+4.54%) | Filing History |
| 2025-04-23 7:55 pm Sale | 2025-03-31 | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 58,880,538 7.600% | -11,282,378 (-16.08%) | Filing History |
| 2025-04-10 06:00 am Sale | 2025-03-31 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | ASTRAZENECA PLC AZN | 25 1.100% | -7 (-21.88%) | Filing History |
| 2025-01-24 09:52 am Purchase | 2025-01-23 | 13D | CELLECTIS S A SPONSORED ADS CLLS | ASTRAZENECA PLC AZN | 44,000,000 44.000% | 28,000,000 (+175.00%) | Filing History |
| 2024-10-28 06:00 am Purchase | 2024-10-23 | 13G | MONOPAR THERAPEUTICS INC MNPR | ASTRAZENECA PLC AZN | 387,329 9.900% | 387,329 (New Position) | Filing History |
| 2024-10-11 06:01 am Purchase | 2024-08-07 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | ASTRAZENECA PLC AZN | 32 9.900% | 32 (New Position) | Filing History |
| 2024-02-12 10:13 am Unchanged | 2023-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | ASTRAZENECA PLC AZN | 4,011,215 4.880% | 0 (Unchanged) | Filing History |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 70,162,916 9.100% | -4,350,285 (-5.84%) | Filing |
| 2023-11-16 11:16 am Unchanged | 2023-11-14 | 13D | CELLECTIS S A SPONSORED ADS CLLS | ASTRAZENECA PLC AZN | 16,000,000 22.400% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:07 pm Purchase | 2023-11-01 | 13D | CELLECTIS S A SPONSORED ADS CLLS | ASTRAZENECA PLC AZN | 16,000,000 22.400% | 16,000,000 (New Position) | Filing History |
| 2023-02-10 10:25 am Unchanged | 2022-12-31 | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 3.400% | 0 (Unchanged) | Filing History |
| 2023-02-10 10:22 am Unchanged | 2022-12-31 | 13G | PIERIS PHARMACEUTICALS INC PIRS | ASTRAZENECA PLC AZN | 44,803 4.800% | 0 (Unchanged) | Filing History |
| 2023-01-24 1:56 pm Sale | 2022-12-31 | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 74,513,201 9.600% | -4,182,452 (-5.31%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 78,695,653 10.200% | 9,229,442 (+13.29%) | Filing |
| 2022-02-07 4:33 pm Purchase | 2021-12-31 | 13G | ASTRAZENECA PLC AZN | BlackRock Inc. BLK | 69,466,211 9.000% | 11,877,811 (+20.63%) | Filing |
| 2022-02-04 09:06 am Sale | 2021-12-31 | 13G | ASTRAZENECA PLC AZN | WELLINGTON MANAGEMENT GROUP LLP | 32,771,181 4.230% | -1,491,483 (-4.35%) | Filing History |
| 2021-07-27 1:20 pm Purchase | 2021-07-20 | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ASTRAZENECA PLC AZN | 884,956 7.300% | 884,956 (New Position) | Filing History |